Chain for claim_257618e57d60417e
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_257618e57d60417e
**Selected angle:** `source` ## One-sentence thesis The cited direct receipts support a bounded working claim: reduced risk of stroke with SGLT2 inhibitors compared to non-SGLT2 inhibitors (HR, 0.83; 95%CI, 0.77-0.91); stroke (RR, 0.61 [95% CI, 0.41-0.91]; P=0.01). **Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims …
sha256 51f6fa416b002570…
depth 1 · source
source_2f2a725457894208
**Selected angle:** `source` ## One-sentence thesis The cited direct receipts support a bounded working claim: reduced risk of stroke with SGLT2 inhibitors compared to non-SGLT2 inhibitors (HR, 0.83; 95%CI, 0.77-0.91); stroke (RR, 0.61 [95% CI, 0.41-0.91]; P=0.01). **Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims…
sha256 cd6a5ea6e1536915…
depth 1 · source
source_9293c06e8a364a23
{"publication_id": "3591803f-c88e-47e8-a088-a212f55ad36d", "traces": [{"candidate_sources": [{"doi": "10.1016/j.phrs.2021.105836", "study": "SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies", "url": null}, {"doi": "10.1161/jaha.123.030578", "study": "Sodium‐Glucose Cotransporter‐2 Inhib…
sha256 ed227cf6d96ec987…
depth 1 · source
source_9b63f4f92d57469c
{"content_hash": null, "edges": [{"from": "3591803f-c88e-47e8-a088-a212f55ad36d", "to": "claim_1", "type": "contains_claim"}, {"from": "3591803f-c88e-47e8-a088-a212f55ad36d", "to": "claim_2", "type": "contains_claim"}, {"from": "3591803f-c88e-47e8-a088-a212f55ad36d", "to": "claim_3", "type": "contains_claim"}, {"from": "3591803f-c88e-47e8-a088-a212f55ad36d", "to": "claim_4", "type": "contains_clai…
sha256 05cd07396e4fd29f…
depth 1 · source
source_921a3d16c5054fc2
{"contradictions": ["_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty f…
sha256 5b73ba8102aad7af…
depth 1 · source
source_14eda58680674192
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Sodium‐Glucose Cotransporter…
sha256 2185a1048294e3a2…
depth 1 · source
source_f6bb14f9772941c3
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "3591803f-c88e-47e8-a088-a212f55ad36d", "sources": [{"directness": "review-level", "doi": "10.1016/j.phrs.2021.105836", "risk_of_bias": "not appraised in public sidecar", "study": "SGLT-2 inhibitors reduce the risk of cerebrovascular/card…
sha256 4d0dbc5151773929…
depth 1 · source
source_96cedc674044468d
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 dce41885d280c6ae…